Cargando…
Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma.
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246484/ https://www.ncbi.nlm.nih.gov/pubmed/2844221 |
_version_ | 1782150781236936704 |
---|---|
author | Joffe, B. I. Kew, M. C. Panz, V. R. Kalk, W. J. Shires, R. Wing, J. Seftel, H. C. |
author_facet | Joffe, B. I. Kew, M. C. Panz, V. R. Kalk, W. J. Shires, R. Wing, J. Seftel, H. C. |
author_sort | Joffe, B. I. |
collection | PubMed |
description | |
format | Text |
id | pubmed-2246484 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1988 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-22464842009-09-10 Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. Joffe, B. I. Kew, M. C. Panz, V. R. Kalk, W. J. Shires, R. Wing, J. Seftel, H. C. Br J Cancer Research Article Nature Publishing Group 1988-07 /pmc/articles/PMC2246484/ /pubmed/2844221 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Joffe, B. I. Kew, M. C. Panz, V. R. Kalk, W. J. Shires, R. Wing, J. Seftel, H. C. Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. |
title | Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. |
title_full | Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. |
title_fullStr | Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. |
title_full_unstemmed | Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. |
title_short | Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. |
title_sort | evaluation of the synthetic somatostatin analogue sms 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246484/ https://www.ncbi.nlm.nih.gov/pubmed/2844221 |
work_keys_str_mv | AT joffebi evaluationofthesyntheticsomatostatinanaloguesms201995inpatientswithhypoglycaemiaassociatedwithhepatocellularcarcinoma AT kewmc evaluationofthesyntheticsomatostatinanaloguesms201995inpatientswithhypoglycaemiaassociatedwithhepatocellularcarcinoma AT panzvr evaluationofthesyntheticsomatostatinanaloguesms201995inpatientswithhypoglycaemiaassociatedwithhepatocellularcarcinoma AT kalkwj evaluationofthesyntheticsomatostatinanaloguesms201995inpatientswithhypoglycaemiaassociatedwithhepatocellularcarcinoma AT shiresr evaluationofthesyntheticsomatostatinanaloguesms201995inpatientswithhypoglycaemiaassociatedwithhepatocellularcarcinoma AT wingj evaluationofthesyntheticsomatostatinanaloguesms201995inpatientswithhypoglycaemiaassociatedwithhepatocellularcarcinoma AT seftelhc evaluationofthesyntheticsomatostatinanaloguesms201995inpatientswithhypoglycaemiaassociatedwithhepatocellularcarcinoma |